Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Trial of Three-weekly Cisplatin and Pemetrexed versus Split-dose Cisplatin and Pemetrexed in Advanced Non-squamous NSCLC
2011-001963-37Phase 2Completed
- Sponsor
- Universitätsmedizin Essen
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Universitätsmedizin Essen. Started Jun 2012; status: completed.
02
Drugs
pemetrexedcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2011-001963-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001963-37.